億緯鋰能(300014.SZ):電池產品目前已向海外頭部一流客户批量供貨
格隆匯5月9日丨億緯鋰能(300014.SZ)於2023年5月6日15:00-17:00召開2022年度業績説明會,問答環節中,就“公司已有軟包電池,方形三元電池出口歐洲等地。公司的磷酸鐵鋰動力電池打算以什麼形式打入海外市場?是出口還是貼近客户在地建設產能?”,公司表示,經過多年發展,公司的電池產品已具備較強的國際競爭力,目前已向海外頭部一流客户批量供貨。公司會根據客户需求,以及結合海內外相關政策,合理佈局規劃產能建設。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.